endoscopic sphincterotomy . Despite that, we had a large sample size and an extended data gathering period (2016-2020) which likely counteracted some of the above concerns.In conclusion, peri-procedural or post-procedural use of clopidogrel bisulfate was not associated with a significant risk of bleeding events following endoscopic sphincterotomy.[0607] Figure 1. Patient counts, exclusions, and groupings for the 13,796 patients in the initial data extraction Table 1. Primary outcome measures for bleeding events (hemoglobin drop >3 g/dL, required transfusion) for patients in the clopidogrel bisulfate (CB), control group (CON, not taking CB), or All patients (ALL). CB (N52,837) CON (N510,870) ALL (N513,707) Hemoglobin Drop .3 and/or Transfusion 28 (0.99%) 95 (0.87%) 123 (0.90%) [0608] Table 1. Clinical course of DFBI based on object sharpness S609
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.